THE TEST THAT DETECTS CONDITIONS BEFORE THE CHILD SHOWS SYMPTOMS
Babynext® helps you prevent damage caused by a diagnosis made too late.
Babynext® does its best for the serenity of your family.
Exome preservation
In addition to reporting on the genes investigated, Babynext® provides exome sequencing, the set of DNA regions that encode the DNA that contain the “instructions” necessary for protein production, whose data will be stored for 18 years.
More and more often, some clinical symptoms cannot be found in routine diagnosis. Genetic testing can solve this problem.
Exome preservation makes genetic data immediately available for a specific exam reducing waiting times for answers and the need for further testing.
Eurofins Genoma: by your children’s side, from birth to adulthood.
- The exome will be stored according to the rules for storing digital data and these data will be accessible until the child reaches adulthood and then transferred to the adult.
- If the child needs to undergo further exams in the future, he or she can always do so at our laboratories: having already stored his or her exome, we will start the analysis without long waits.
- The results of these further exams will then be discussed in a new genetic consultation for the result.
Who is Babynext® recommended for?
It is advisable to carry out as soon as possible for a timely diagnosis and possible taking charge of the child. All children, from birth to 3 years even without apparent symptoms.
Exome preservation can also be extended to older brothers and sisters.
How is it performed?
The Babynext® test is performed with a simple mouth swab. You can request it from your trusted doctor or book it at one of our centers.
Genetic counseling pre- and post-test is included with Babynext®.
Conditions detected by Babynext®
Babynext® performs early screening for numerous genetic conditions and identifies them in the early stages of life, allowing parents and pediatricians to take prompt action in terms of clinical checks, treatment, and lifestyle modifications.
Why choose Babynext®?
Early Diagnosis
Babynext® allows for the early identification of diseases, even before symptoms manifest.
Targeted Therapy
Babynext® allows the doctor to identify and develop a personalized therapeutic plan.
Cutting-Edge Technology
Babynext® combines screening over 200 genes, connected to 280 conditions, with whole exome sequencing.
Results Preserved Over Time
The exome data is stored and can be consulted until the child reaches adulthood.
Your essential resource for better prevention.
Functional
For all conditions identified by Babynext® there is a treatment, which may involve the use of drugs, supplements, or lifestyle changes based on the doctor’s recommendation.
Advanced
Uses innovative and sophisticated techniques.
Useful
The preservation of the exome allows for the data to be already available for future exams, greatly reducing wait times for answers.
Fast
Results are ready in 45 working days.
Quality. Excellence. Innovation.
Considered one of the most advanced European molecular diagnostic laboratories, it is an internationally recognized center for the great wealth of technologies and human resources that characterize it.
Since 1997 it has primarily operated as a diagnostic partner for genetic, cytogenetic and molecular analysis: it is a company active in research and boasts unrivaled knowledge and experience in the sector. It offers a combination of advanced technologies and patient care that ensure increasingly accurate diagnoses.
The laboratories, located within modern and high-tech facilities, are characterized by advanced instrumental and technological equipment, as well as high quality standards.
Eurofins Genoma provides a wide range of services among the most complete in the national and international territory, offering patients and their doctors innovative diagnostic solutions for any clinical need.